in a Bio magazine ( possibly called Drugs and Deals ) from 2014 where Tim stated that he honestly believed that SAREUM would succumb to buyout by a major Pharma as he fully expected milestone payments at some point in the not too distant future to exceed SAR,s MCAP. Can't be bad.
Azn will take a licence for use with its wee1 inhibitor. Whether this later in the year. Over the summer. Or before next weekends azn pipeline presentations at ASCO. But imho it's coming. Sooner than many expected. DYOR imho etc
i think you know the answer.... but in case you do not it is not a problem as you will see the other side of the coin soon. Recently I heard the ALL-Cons was praying all GODS of any faith to get his cheap entry.... are you in the same boat? ATB
One of AZN DDR dugs is a wee inhibitor (in article). It is very effective when combined with a chk1 inhibitor (see diagram near bottom of article).
only problem is AZN doesnt have an active chk1 program any more. and we are the ones in the clinic available to licence. buy hey ho so much conjecture. surely there would be some literature or something on the two together. ......
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.